These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 31799)

  • 1. Endocrine testing in tardive dyskinesias: preliminary report.
    Rosenbaum AH; Maruta T; Jiang NS; Auger RG; de la Fuente JR; Duane DD
    Am J Psychiatry; 1979 Jan; 136(1):102-3. PubMed ID: 31799
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of state-dependent reversal of tardive dyskinesia: phenomenological probe in humans.
    Goswami U; Narayanan HS; Channabasavanna SM
    J Clin Psychopharmacol; 1985 Feb; 5(1):48-50. PubMed ID: 2857733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium intraerythrocyte levels in tardive dyskinesia: a preliminary report.
    Yassa R; Schwartz G; Wood P
    Biol Psychiatry; 1983 Jul; 18(7):825-8. PubMed ID: 6137247
    [No Abstract]   [Full Text] [Related]  

  • 4. Depression as a predictor in the development of tardive dyskinesia.
    Yassa R; Schwartz G
    Biol Psychiatry; 1984 Mar; 19(3):441-4. PubMed ID: 6144331
    [No Abstract]   [Full Text] [Related]  

  • 5. Depression-dependent tardive dyskinesia.
    Herrán A; Vázquez-Barquero JL
    J Neuropsychiatry Clin Neurosci; 1999; 11(3):413-4. PubMed ID: 10440024
    [No Abstract]   [Full Text] [Related]  

  • 6. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM
    J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and pathophysiology of tardive dyskinesias.
    Klawans HL; Tanner CM; Goetz CG
    Adv Neurol; 1988; 49():185-97. PubMed ID: 2894124
    [No Abstract]   [Full Text] [Related]  

  • 9. Tardive dyskinesia in patients receiving lithium maintenance therapy.
    Perényi A; Szücs R; Frecska E
    Biol Psychiatry; 1984 Nov; 19(11):1573-8. PubMed ID: 6151403
    [No Abstract]   [Full Text] [Related]  

  • 10. Tardive dyskinesia and ziprasidone.
    Rosenquist KJ; Walker SS; Ghaemi SN
    Am J Psychiatry; 2002 Aug; 159(8):1436. PubMed ID: 12153846
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of tardive dyskinesia and mania with RBC lithium determinations.
    Ereshefsky L; Rubin TN; Friedman S
    Am J Psychiatry; 1979 Apr; 136(4B):570-3. PubMed ID: 34329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment-emergent tardive dyskinesia with quetiapine in mood disorders.
    Sharma V
    J Clin Psychopharmacol; 2003 Aug; 23(4):415-7. PubMed ID: 12920421
    [No Abstract]   [Full Text] [Related]  

  • 13. Tardive dyskinesia and the primary psychiatric diagnosis.
    Yassa R; Nair V; Schwartz G
    Psychosomatics; 1984 Feb; 25(2):135-8. PubMed ID: 6142494
    [No Abstract]   [Full Text] [Related]  

  • 14. Risperidone-induced tardive dyskinesia and parkinsonism.
    Gwinn KA; Caviness JN
    Mov Disord; 1997 Jan; 12(1):119-21. PubMed ID: 8990067
    [No Abstract]   [Full Text] [Related]  

  • 15. Tardive dyskinesia syndrome in neuroleptic therapy. General considerations and clinical observations on forty cases investigated.
    Chiriţă V; Boişteanu P; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(1):53-64. PubMed ID: 2889249
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia.
    Souza RP; Remington G; Meltzer HY; Lieberman JA; Kennedy JL; Wong AH
    Int Clin Psychopharmacol; 2010 Sep; 25(5):264-9. PubMed ID: 20436352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
    Wolf ME; DeWolfe AS; Mosnaim AD
    Hillside J Clin Psychiatry; 1987; 9(1):3-11. PubMed ID: 2888712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine-related tardive dyskinesia.
    Ghaemi SN; Ko JY
    Am J Psychiatry; 2001 Oct; 158(10):1737. PubMed ID: 11579018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.